
Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>




































Human BAFF Protein, His,Flag Tag (Cat. No. BAF-H52D4) stimulates proliferation of mouse spleen cells. The EC50 for this effect is 1.97-2.90 ng/mL (Routinely tested).

Human BAFFR Protein, Fc Tag (Cat. No. BAR-H5257) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human BAFF Protein, His,Flag Tag (Cat. No. BAF-H52D4) with an affinity constant of 5.54 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Telitacicept | RCT-18; RC-18; RCT18; RC18 | Approved | RemeGen Co Ltd | 泰爱 | Mainland China | Lupus Erythematosus, Systemic | RemeGen Co Ltd | 2021-03-09 | Myasthenia Gravis; Multiple Sclerosis, Relapsing-Remitting; Glomerulonephritis, IGA; Arthritis, Rheumatoid; Sjogren's Syndrome; Multiple Sclerosis; Lupus Erythematosus, Systemic; Neuromyelitis Optica | Details |
| Belimumab | BmAb; HGS-1006; GSK-1550188 | Approved | Glaxosmithkline Plc | Benlysta, 倍力腾 | Mainland China | Lupus Nephritis | Glaxosmithkline (China) Investment Co Ltd | 2011-03-09 | Glomerulonephritis, Membranous; Leukemia, Lymphocytic, Chronic, B-Cell; Pulmonary Disease, Chronic Obstructive; Waldenstrom Macroglobulinemia; Emphysema; Lymphopenia; Sjogren-Larsson Syndrome; Lupus Erythematosus, Systemic; Antiphospholipid Syndrome; Rejection of renal transplantation; Lupus Nephritis; Purpura; Graft vs Host Disease; Arthritis, Rheumatoid; Myositis; Granulomatosis with Polyangiitis; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| hCBE-11 | hCBE-11 | Biogen Inc | Details | ||
| UBP-1213 | UBP-1213 | Phase 1 Clinical | Wuhan Huaxin Kangyuan Biomedicine Co Ltd, Shanghai Junshi Biosciences Co Ltd | Lupus Erythematosus, Systemic | Details |
| Tabalumab | LY-2127399 | Phase 2 Clinical | Eli Lilly And Company | Multiple Sclerosis, Relapsing-Remitting; Dermatomyositis; Arthritis, Rheumatoid; Autoimmune Diseases; Scleroderma, Systemic; Multiple Myeloma; Connective Tissue Diseases; Arthritis, Juvenile; Multiple Sclerosis; Lupus Erythematosus, Systemic; Kidney Failure, Chronic; Pemphigus | Details |
| Atacicept | TACI-Ig | Phase 3 Clinical | Zymogenetics Inc | Glomerulonephritis, IGA; Arthritis, Rheumatoid; Multiple Sclerosis; Optic Neuritis; Lupus Nephritis; Lupus Erythematosus, Systemic | Details |
| Rozibafusp alfa | AMG-570; MEDI-0700 | Phase 2 Clinical | Amgen Inc | Arthritis, Rheumatoid; Lupus Erythematosus, Systemic | Details |
This web search service is supported by Google Inc.




